Assessing the Response Rate of Neo-adjuvant Taxotere and Trastuzumab in Nigerian Women With Breast Cancer
Clinical trial NCT03879577 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT03879577
- Sponsor
- University of Chicago
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2019-11-25
- Primary completion
- 2023-03-30
- Enrollment
- 53
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.